Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (751-760 of 1,417) with videos related to

Pageof 142
Sort By:
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Minerva Medica|June 12, 2020
HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantationFrancesca Ziviello, Thomas Pilgrim, Herbert Kroon, et al.
Open Heart|June 3, 2016
Health utility indexes in patients with acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
The American Journal of Cardiology|October 21, 2016
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial InfarctionRaffaele Piccolo, Gennaro Galasso, Ingo Eitel, et al.
JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.
Pageof 142

Showing results (751-760 of 1,417) with videos related to

Sort By:
Pageof 142
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Minerva Medica|June 12, 2020
HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantationFrancesca Ziviello, Thomas Pilgrim, Herbert Kroon, et al.
Open Heart|June 3, 2016
Health utility indexes in patients with acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
The American Journal of Cardiology|October 21, 2016
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial InfarctionRaffaele Piccolo, Gennaro Galasso, Ingo Eitel, et al.
JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.
Pageof 142